Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Procaps Group, S.A. (PROC)

7.7008   0.201 (2.68%) 05-16 01:38
Open: 7.7008 Pre. Close: 7.5
High: 7.76 Low: 7.24
Volume: 239 Market Cap: 869(M)
Procaps Group, S.A. operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately ten therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg City, Luxembourg.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.77 - 7.8 7.8 - 7.84
Low: 7.15 - 7.19 7.19 - 7.23
Close: 7.63 - 7.7 7.7 - 7.76

Technical analysis

as of: 2022-05-13 4:40:43 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 9.99     One year: 11.67
Support: Support1: 7.28    Support2: 6.5
Resistance: Resistance1: 8.56    Resistance2: 9.99
Pivot: 7.73
Moving Average: MA(5): 7.51     MA(20): 7.82
MA(100): 8.73     MA(250): 9.48
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 53.2     %D(3): 45.4
RSI: RSI(14): 45.2
52-week: High: 11.97  Low: 6.5
Average Vol(K): 3-Month: 39 (K)  10-Days: 23 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PROC ] has closed above bottom band by 47.2%. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 13 May 2022
Comelec to also limit attendance during PL proc - Manila Bulletin

Mon, 28 Feb 2022
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles -

Mon, 28 Feb 2022
Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample -

Mon, 28 Feb 2022
Community structure in social and biological networks -

Thu, 03 Feb 2022
Faulkner v. Broadway Festivals, Inc., Adv. Proc. 20-05031 (Bankr. N.D. – Tex., January 11, 2022) - JD Supra

Mon, 31 Jan 2022
List of automatic tax method changes updated - Journal of Accountancy

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 113 (M)
Shares Float 0 (M)
% Held by Insiders 86.7 (%)
% Held by Institutions 5.6 (%)
Shares Short 485 (K)
Shares Short P.Month 480 (K)

Stock Financials

EPS -5.22
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -127.67
Profit Margin (%) -11.3
Operating Margin (%) 17.7
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 34.7
Gross Profit (p.s.) 1.69
Sales Per Share 3.55
EBITDA (p.s.) 0.72
Qtrly Earnings Growth 0
Operating Cash Flow 35 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -1.48
PEG Ratio 0
Price to Book value -0.07
Price to Sales 2.16
Price to Cash Flow 25.09

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.